BIONOMICS LIMITED (ASX:BNO)
http://www.bionomics.com.au/
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Activity: Developer of innovative treatments for cancer, mutiple sclerosis, anxiety and epilepsy.
31 Dalgleish Street THEBARTON SA 5031
Ph: 08 8354 6100    Fax: 08 8354 6199
Dr Deborah Rathjen
Bionomics Limited presents at the ASX Small to Mid Caps conference in New York
Mon, 2 Apr 2012 1:00pm
Deborah Rathjen, CEO and Managing Director
Dr Deborah Rathjen
Bionomics targets Alzheimer`s Disease
Mon, 20 Feb 2012 11:05am
Dr Deborah Rathjen, Managing Director
Dr Deborah Rathjen
Bionomics 2011 Annual General Meeting
Fri, 11 Nov 2011 9:45am
Dr Deborah Rathjen, Managing Director, CEO
Dr Deborah Rathjen
Bionomics Limited - ASX Small to Mid Caps Conference in Singapore and Hong Kong
Fri, 4 Nov 2011 11:25am
Deborah Rathjen, Managing Director & CEO
Dr Deborah Rathjen
Bionomics to present at the ASX Small to Mid Caps conference in Hong Kong and Singapore
Thu, 6 Oct 2011 10:15am
Dr Deborah Rathjen, CEO
Dr Deborah Rathjen
Clinical trials reach key milestones for Bionomics
Fri, 12 Aug 2011 11:30am
Dr Deborah Rathjen, Managing Director
Dr Deborah Rathjen
Bionomics Anti-Anxiety Drug Clinical Trials Successful Results - Dr Deborah Rathjen, Managing Director & CEO
Tue, 5 Apr 2011 2:00pm
Dr Deborah Rathjen
BNC210 - European Approval Granted for Two Phase Ib Trials - Dr Deborah Rathjen, Managing Director
Mon, 11 Oct 2010 11:00am
Dr Deborah Rathjen
Second BNC210 Phase 1 Clinical Trial Commences - Dr Deborah Rathjen, Managing Director & CEO
Thu, 13 May 2010 10:30am
BNC210 is being developed for the treatment of anxiety and depression
Dr Deborah Rathjen
Bionomics Provides Update on BNC105 and BNC210
Thu, 4 Feb 2010 12:30pm
Icon_lastIcon_nextIcon_previousIcon_first

Executives & Directors

Mr Chris Fullerton
Chairman
Dr Deborah Rathjen
Managing Director, CEO
Dr Errol De Souza
Non Exec. Director
Mr Trevor Tappenden
Non Exec. Director
Ms Melanie Young
CFO
Ms Melanie Young
Secretary
Please contact the ASX to change these details

Company Podcasts

Subscribe to current and future audio events for BNO Podcast of events for BIONOMICS LIMITED
Interim Results
Tue, 14 Feb 2012
Annual General Meeting
Wed, 9 Nov 2011
Interim Results
Fri, 11 Feb 2011
Annual General Meeting
Wed, 13 Oct 2010
Annual General Meeting
Wed, 4 Nov 2009 3:00pm
EGM
Fri, 9 Oct 2009 11:00am
Full Year Results
Fri, 28 Aug 2009
Interim Results
Wed, 25 Feb 2009
Annual General Meeting
Wed, 5 Nov 2008 11:00am
Annual General Meeting
Wed, 7 Nov 2007 10:30am
Click here to view details on the ASX site
Change of Director`s Interest Notice Mon, 7 May 2012
Appendix 3B Thu, 3 May 2012
Appendix 4C - quarterly Mon, 30 Apr 2012
Joint Bionomics and Ironwood Roadshow Wed, 18 Apr 2012
Change of Director`s Interest Notice Tue, 17 Apr 2012
Appendix 3B Tue, 17 Apr 2012
Open Briefing - CEO on BNC105 Ovarian Cancer Trial Tue, 3 Apr 2012
BNC105 Ovarian Cancer Progress Mon, 2 Apr 2012
Appendix 3B Tue, 27 Mar 2012
BNC105 Ovarian Cancer Trial Approved Fri, 23 Mar 2012

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.